Clinical Trials Directory

Trials / Sponsors / Mesoblast International Sàrl

Mesoblast International Sàrl

Industry · 5 registered clinical trials.

StatusTrialPhaseStarted
CompletedFollow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following Meniscectomy
Recovery Following Partial Medial Meniscectomy
Phase 1 / Phase 22008-06-01
CompletedA Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
Recovery Following Partial Medial Meniscectomy
Phase 1 / Phase 22005-09-01
WithdrawnOTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Ste
Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes
Phase 2—
No Longer AvailableIntermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)
——
No Longer AvailableIntermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distres
Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19
——